Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder

NCT05053503 is registered in ClinicalTrials.gov with Spark Biomedical, Inc. as lead sponsor.

NCT NCT05053503
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05053503 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder
Lead sponsor
Spark Biomedical, Inc.
Phase
Not applicable
Overall status
Completed
Start date
May 27, 2022
Completion date
April 4, 2025
Enrollment
108 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

opioid withdrawal, opioid-use disorder